vishal singh
The Pennsylvania State University (PSU)
University Park, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
ajantha sinniah
University of Malaya
Kuala Lumpur, Malaysia
Review Editor
Pharmacology of Anti-Cancer Drugs
md afjalus siraj
Yale University
New Haven, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
vijay sirohi
University of Florida
Gainesville, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
michelle siu
The University of Hong Kong
Pokfulam, Hong Kong, SAR China
Review Editor
Pharmacology of Anti-Cancer Drugs
todd skaar
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
todd skaar
Indiana University
Bloomington, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
marcelo sobral-leite
The Netherlands Cancer Institute (NKI)
Amsterdam, Netherlands
Review Editor
Pharmacology of Anti-Cancer Drugs
federica sodano
University of Turin
Turin, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
sameh s.m. soliman
University of Sharjah
Sharjah, United Arab Emirates
Review Editor
Pharmacology of Anti-Cancer Drugs
botao song
Northwest University
Xi'an, China
Review Editor
Pharmacology of Anti-Cancer Drugs
mengqiu song
Zhengzhou University
Zhengzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
yongbo song
Shenyang Pharmaceutical University
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
alexander t. sougiannis md, phd
Wexner Medical Center, The Ohio State University
Columbus, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
joshi stephen
Human Genome Sequencing Center, Baylor College of Medicine
Houston, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
christian stockmann
University of Zurich
Zürich, Switzerland
Review Editor
Pharmacology of Anti-Cancer Drugs